chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received vaccination on 3/16 at 11:00 am, first bloody nose on 3/17 at 7:15 am, second bloody nose on 3/19 at 7:00 am.  No history of bloody nose.
Patient knew from previous reactions that she should be  cautious and had contacted shot givers ahead of time with concerns. She was advised to pre-treat with Benadryl 50mg and  famotidine 40mg before the vaccination. Pt. had no immediate reactions and continued to be symptom free for 3+ hours after vaccination. At onset, she experiencing soreness in her mouth that then extended to a "full" feeling in her face and difficulty swallowing due to a sensation of swelling in her throat. She called a colleague who advised to take  more Benadryl  and ready and Epi-Pen. She kept Epi-Pen on standby but never administered it, she did take another 25mg of Benadryl which made her feel better after another 20-30 minutes. She monitored through the evening at her home, slept overnight and is back at work this morning with no more symptoms and only a sore arm near the injection site.
Pt recvd Hep B vax on 23FEB91 & the following day pt exp palpitation, chest discomfort, bronchial spasm, angioedema, dyspnea, pruritus, urticaria, edema, arthritis, fever, erythema nodosum, rhinitis, cough, cramping, & dyspepsia; thrush;
Began evening of 02/11/2021 with injection site soreness, severe body ache, headache, severe body chills, slight fever and night sweats. Finally subsided by evening of 02/13/2021.
**Case was involved in a serious house fire . He suffered multiple burns. Was tested in hospital and is currently in the  Burn Unit at Hospital. No known COVID symptoms reported by family members.
This spontaneous report was received from a medical assistant and refers to a 7 month old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 10-JUL-2017, the patient was vaccinated with a second dose of ROTATEQ orally (lot # M041766, expiration date 08-MAY-2018). On 14-JUL-2017, the patient was vaccinated with a third dose of ROTATEQ orally (lot# M041766, expiration date: 08-MAY-2018). No adverse effects were reported. Additional information is not expected, no consent to contact reporter.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Mar2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 04Apr2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 11Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 32 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Obesity" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Result. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Antiviral details: The patient received Paxlovid, antiviral drug treatment on 04Jul2022 to 09Jul2022 for an COVID-19. The patient did not had any known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
she has been having abdominal pain; This spontaneous report as received from a pharmacist refers to a non-pregnant 13-year-old female patient. There were no patient's concurrent conditions, medical history and concomitant therapies.    The patient had her 2nd injection with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) intramuscularly (strength, dose, lot number, expiration date were unknown) for prophylaxis (reported as "Cervical, vulvar, vaginal, anal, oropharyngeal and other head and neck cancers caused by Human Papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 58, Genital warts (condyloma acuminata) caused by HPV types 6 and 11, And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52,and 58: Cervical intraepithelial neoplasia (CIN) grade 2/3 and cervical adenocarcinoma in situ (AIS), Cervical intraepithelial neoplasia (CIN) grade 1, Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3, Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3, Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3") on 15-JUN-2021. Since 22-JUN-2021, she had been having abdominal pain. It had been off and on since then. She gave it about 1-2 level of pain out of 10, sometimes her pain was 6-7. She was still having abdominal pain yesterday and into this morning." No treatment was given for the event. There were no laboratory/studies performed. The patient did not seek for medical attention.   At the time of reporting, the outcome of the event was considered to be not resolved. The causality was not provided.
8/4/10 mom called to report patient complaining of pain right leg and not wanting to walk.  No redness at injection site, no swelling feels warm to touch.  No fever.
Patient received PREVNAR 13 vaccination on 8/6/15. Patient came into pharmacy on 8/12/15, complaining of itching left arm at injection site. Arm was red rash front deltoid to mid upper arm. Arm was hot to touch, red, blotchy and itchy.
32 y/o male, c/o itching to forearm, lips, 6 hours after receiving flu iz, no SOB, without wheezing. No localized rxn at site. Lungs clear. BP 118/64, P 84, O2 sat 100%.
Vaccine received on 2/22/11 to ER on 2/23/11, early AM with generalized tonic clonic seizure. No studies done - felt related to vaccine.
Rapid heart beat; Severe chest pain; Pain was so bad she was afraid to move; She was petrified because thought she was having a heart attack; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Rapid heart beat), CHEST PAIN (Severe chest pain), PAIN (Pain was so bad she was afraid to move) and FEAR (She was petrified because thought she was having a heart attack) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced HEART RATE INCREASED (Rapid heart beat), CHEST PAIN (Severe chest pain), PAIN (Pain was so bad she was afraid to move) and FEAR (She was petrified because thought she was having a heart attack). At the time of the report, HEART RATE INCREASED (Rapid heart beat), CHEST PAIN (Severe chest pain), PAIN (Pain was so bad she was afraid to move) and FEAR (She was petrified because thought she was having a heart attack) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.   Reporter did not allow further contact
swollen tongue; hives on the left side of her body including the back of her arm, hip, elbow and foot; muscle pain; This spontaneous case was reported by a nurse and describes the occurrence of SWOLLEN TONGUE (swollen tongue), URTICARIA (hives on the left side of her body including the back of her arm, hip, elbow and foot) and MYALGIA (muscle pain) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021 at 12:10 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced SWOLLEN TONGUE (swollen tongue), URTICARIA (hives on the left side of her body including the back of her arm, hip, elbow and foot) and MYALGIA (muscle pain). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, SWOLLEN TONGUE (swollen tongue), URTICARIA (hives on the left side of her body including the back of her arm, hip, elbow and foot) and MYALGIA (muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered SWOLLEN TONGUE (swollen tongue), URTICARIA (hives on the left side of her body including the back of her arm, hip, elbow and foot) and MYALGIA (muscle pain) to be probably related.    No concomitant medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Patient demographics, event start date added
lethargic; overly tired; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargic) and FATIGUE (overly tired) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Medical history is not provided by the Reporter.  Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), ACETYLSALICYLIC ACID (BABY ASPIRIN), FEXOFENADINE HYDROCHLORIDE (ALLEGRA), VITAMIN D3 and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced LETHARGY (lethargic) and FATIGUE (overly tired). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1000 milligram once a day. On 28-Mar-2021, LETHARGY (lethargic) and FATIGUE (overly tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Shortly after patient received flu vaccine, she experienced hot flashes, heavy breathing, dizziness, sudden back spasms. Patient received flu vaccine at pharmacy in the past but has never had this type of reaction before. When police and EMS arrived, patient recovered and felt better. Patient refused transport to hospital. Patient was well when she left the pharmacy.
patient called me today before her second covid shot which was scheduled for 05/18/2021.  Asked if she would have a reaction like the last time.  I asked for more information as to what happened as this was unknown to us.  1st moderna covid dose was administered 04/20/2021 2 days later she presented to the medical center ER for fever migrain headache and facial numbness (swelling?).  That ER turned her away as they claimed to have no beds available for her.  she then went to her pcp clinic   was seen and treated for migraine.  Was told she was ok to receive a second dose per the patient.  I can't confirm this.  I spoke with nurse and she was going to contact the MD who saw her and if patient could get the vaccine again.  If so we agreed that their clinic would be the best location.
Received shots 11/21/2002, on Sunday infant started crying all day - nonstop.  Temp from 99 degrees to 100.2.  When named called child daydreams wouldn't respond when name called wouldn't just spaced out.  Went to Doctor on 11/26/02 temp 100.4.
10/2/2015 - Received influenza vaccination. 10/5/2015 - Extreme fatigue and weakness, loss of balance, left deltoid numbness, left thumb numbness. 10/25/2015 - Abnormal gait, worsening fatigue, difficulty lifting. 12/21/2015 Diagnosed with Transverse Myelitis.
HOT, TENDER, SWOLLEN, RASH. TREATED WITH KEFLEX.
Yesterday, March 15th, I woke with a rash on my neck and swollen eye lids, just like an allergic reaction.  I have not eaten anything new, nor taken any new medications or over-the counter supplements since I received my shot.  Could I have a delayed allergic reaction?
Hives a few hours after vaccine. BENADRYL 25 mg on 11/4/09.
Patient says her arm has been itching since she received the vaccination. She does not have any other symptoms. Also no redness or rash.
"Covid" arm rash on right arm, it started as a small spot on my arm and has now spread to 3/4 quarter of my upper arm.  Its bright red, itchy, and hot to touch.
Arm felt heavy; Arm felt tingly/ Also felt this around her face; Arm felt numb/ Also felt this around her face; This spontaneous case was reported by an other health care professional and describes the occurrence of   in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  No concomitant medication was provided.
12-9-08 Vaccines given.  12/11/08 Fussy since vaccines.  Fever off and on T 101.6 decrease appetite.  Seen by Doctor - Pharyngitis, GE reflux.  TYLENOL after 4 hrs.  12-12-08 Temp down.
Patient is still having arm pain in the left arm 9 months after vaccine.  Has followed up with their physician assistant.
Right arm swollen, red hot to touch noted the eve after vaccine administered. Patient complained of pain and puritis. Patient tp clinic for assessment. Advised hot compresses and return if fever develops or no improvement.
no strength in lt arm & lt leg; starting 5NOV92 afternoon; went to local ER @ 330- 6NOV92; was given Ibuprophen;
Woke from sound sleep  at 4 am (approximately 14 hours after having the vaccine shot) -- chilled, and every part of body hurt. Went back to bed.  6 am still hurt everywhere, short of breath (oxygen concentration at 90 and sometimes below--thankfully I had oxygen as I sleep with it).  Running a temperature of 100., disoriented, heart rate at 115+ and I hurt everywhere.  8 am called Dr. & left call-back.  1 pm tried Dr. again.  Told person on telephone and he told Nurse Practitioner.  They ordered nose spray because I mentioned I may have a sinus infection as my head hurt, my ears hurt.  I continued Tylenol every 6 hours on Friday and Saturday (all day).  I was able to get up and do a few things on Saturday.  Felt better on Sunday but still weak feeling.  Oxygen saturation back to 95-96 and heart rate under 100.
Patient received 1st dose of AVA on 02/10/99 and developed rash within 3 days on stomach and legs. Rash resolved prior to second dose on 02/24/99. Within a few days the rash came back worse and has never resolved. Rash on face, legs, shins abdomen, genital area. Patient also has joint pains, pain in neck, spine and lower back. Patient received 3 more doses of anthrax vaccine: 03/19/99 FAV033, 08/26/99 FAV039, 02/28/00 FAV024 until military ran out of vaccine. Patient was medically discharged December 2003. Was diagnosed with psoriasis.
fever; congestion; lethargy; confusion; spacy dizziness; body aches; tired; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 41-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on 19Mar2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient had congestion, lethargy, confusion, spacy dizziness, tired and body aches on an unspecified date in 2021. She had a fever that morning (21Apr2021) but it went down. The patient was not sure if her symptoms are normal or the severity was normal. The patient asked how long the symptoms should last finally. The outcome of congestion, lethargy, confusion, spacy dizziness, tired and body aches was unknown at the reporting time. The outcome of fever was recovered on 21Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report as received from an approximately 84 year old female consumer with medical history included shingles in 2008 before having the vaccine. Drug history of cefadroxil (manufacturer unknown) and aspirin reaction/allergy. In 2012 (reported as last year), the patient was vaccinated with ZOSTAVAX, route reported as injection, (lot and dose not reported) for prevention of shingles. There was no concomitant medication. In 2012 (reported as last year), the patient experienced a stroke. In approximately July 2013 (reported as approximately 3-4 months ago), the patient experienced painful, itching "shingles pimple" on her leg after having ZOSTAVAX last year. The outbreaks occurred when the patient got nervous or upset. The reactions last for approximately 2 days before resolving. The patient did not seek for medical attention. No lab diagnostics performed. The patient had been treating the outbreaks with a dried flour at home treatment and felt that salves and ointments did not help as much as keeping the area dry. The outcome of stroke was not reported. The outcome of painful, itching "shingles pimple" on her leg was reported as not recovered. Upon internal review stroke was considered to be medically significant. Additional information has been requested.
Day 7 post vaccination left arm begun to turn very itchy, red and heavily painful. Along with strong pain on my left side of my forehead, nauseas and feeling dizzied.
Initial unsolicited report received from a pharmacist (Director of Pharmacy) on 12 October 2016. This case is linked with 2016SA189772, 2016SA189781, 2016SA189791, 2016SA189792, 2016SA189793, 2016SA189794, 2016SA189795, 2016SA189796, 2016SA189797, 2016SA189798, 2016SA189799, 2016SA189800, 2016SA189801, 2016SA189802, 2016SA189803, 2016SA189804, 2016SA189805, 2016SA189806, 2016SA189807, 2016SA189808, 2016SA189809, 2016SA189810, 2016SA189811, 2016SA189812, 2016SA189813, 2016SA189814, 2016SA189815, 2016SA189816, 2016SA189817, 2016SA189818, 2016SA189819, 2016SA189820, 2016SA189821, 2016SA189822, 2016SA189823,2016SA189824, 2016SA189825, 2016SA189826, 2016SA189827, 2016SA189828, 2016SA189829, 2016SA189830, 2016SA189831, 2016SA189833, 2016SA189834, 2016SA189835, 2016SA189836, 2016SA189837, 2016SA189838, 2016SA189839, 2016SA189840, 2016SA189841, 2016SA189842, 2016SA189843, 2016SA189844, 2016SA189845, 2016SA189846, 2016SA189847, 2016SA189848. This case involves a patient (age an d gender not reported) who was vaccinated with a dose FLUZONE)(batch number:UI669AA, expiration date: 30 June 2017 and site of administration was not reported) intramuscularly, on an unspecified date (over the past month). Patient's Illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects, medical conditions was reported as unknown. Concomitant medication was not reported. On an unspecified date (over the past month), following the vaccination, the patient had large red spot, warm to touch and raised hard spot. It was reported that the patient required emergency room or doctor visit. Lab data and corrective treatment were not reported. The outcome of the events was reported as unknown. List of documents held by sender: none.
pt states tingling sensation in legs started a week after the vaccine.  he still has those symptoms today. pt will contact his doctor
At 36 hrs post 2nd dose severe left jaw and maxillary sinus pain overnight. At 72 hrs post 2nd dose dermal fillers injected February 3rd under eye, on right side became lumpy. A lump and then a ridge; eye puffiness; eye swelling; This is a spontaneous report from a contactable other hcp. A 63-years-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: ER8735), via an unspecified route of administration, administered in Arm Left (at age of 63 years) on 12Apr2021 12:00 as 2nd dose, single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included cetirizine hydrochloride (ZYRTEC ALLERGY), fluticasone propionate (FLONASE ALLERGY RELIEF). The patiently previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in Arm Left on 15Mar2021 as 1st dose, single dose for covid-19 immunisation (at the age of 63 years). No other vaccine in four weeks was given to patient. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies. It was reported that at 36 hours post 2nd dose severe left jaw and maxillary sinus pain overnight. At 72 hours post 2nd dose dermal fillers injected February 3rd under eye, on right side became lumpy. A lump and then a ridge developed, as well as bilateral under eye puffiness. This prompted an initial visit to dentist with follow up, oral surgeon. Visit to D.O. Regarding filler bumps. Then visit to dermatologist for unresolved bump/ridge and under eye swelling. Finally, a visit to plastic surgeon. The outcome of the events was reported as not recovered.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the events, sinus pain, eye swelling, face swelling cannot be completely ruled out. The impact of this report on benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethic committees, and Investigators, as appropriate.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 26-SEP-2013 the patient was vaccinated with M-M-R II (reported lot # H018950 corresponding with lot # 1483AA; expiration date 18-OCT-2014). The vaccine was exposed to temperature exposures of 50F for 85 minutes, 47F for 15 minutes, 48F for 35 minutes, 52 F for 95 minutes, 48F for 30 minutes on 20-SEP-2013 and 48F for 45 minutes on 25-SEP-2013. No known adverse effects. This case is linked to case 1310USA001610, 1310USA008360, 1310USA008361, 1310USA008362, 1310USA008363, 1310USA008364, 1310USA008365, 1310USA008366, 1310USA008367, 1310USA008368, 1310USA008369, 1310USA008370, 1310USA008371, 1310USA008372; 1310USA008373, 1310USA008374; 1310USA008375; 1310USA008376; 1310USA008377; 1310USA008378; 1310USA008379; 1310USA008380; 1310USA008381; 1310USA008382; 1310USA008383; 1310USA008384; 1310USA008385; 1310USA008386; 1310USA008388; 1310USA008389; 1310USA008390; 1310USA008391; 1310USA008392; 1310USA008393; 1310USA008394; 1310USA008395; 1310USA008396; 1310USA008397; 1310USA008398; 1310USA008399; 1310USA008400; 1310USA008401; 1310USA008402; 1310USA008403; 1310USA008404; 1310USA008405; 1310USA008406 and 1310USA008407 (same reporter linked). Additional information has been requested.
10 days after first dose broke out in itchy hives. They covered inner biceps and forearms (both arms), torso, groin and outter thigh/calf (both legs). Accompanied by some fatigue and slight weakness. One dose of benadryl at about 2am the morning of 4/14 helped curb the itchiness, but the bumps and fatigue remain.
Received a Moderna booster vaccine on 8/24/2022 and again on 8/31/2022.